World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
26028
World Ranking
13249
National Ranking
507

Overview

Gabriella Ferrandina is affiliated with the Catholic University of the Sacred Heart in Italy. The primary field of research is Medicine, with a focus on several related subfields such as Obstetrics and Gynecology, Reproductive Medicine, Epidemiology, Surgery, and Oncology.

The main topics of Gabriella Ferrandina's work include:

  • Endometrial and Cervical Cancer Treatments
  • Ovarian cancer diagnosis and treatment
  • Cervical Cancer and HPV Research
  • Endometriosis Research and Treatment
  • Uterine Myomas and Treatments
  • Radiomics and Machine Learning in Medical Imaging
  • Colorectal and Anal Carcinomas

Frequent co-authors in Gabriella Ferrandina's research network include:

  • Giovanni Scambia
  • Gabriella Macchia
  • Nicolò Bizzarri
  • Luigi Pedone Anchora
  • Francesco Fanfani

Gabriella Ferrandina has contributed publications to various scientific venues, with a number of papers appearing in:

  • International Journal of Gynecological Cancer
  • Radiotherapy and Oncology
  • European Journal of Surgical Oncology
  • Gynecologic Oncology
  • Annals of Surgical Oncology

Recent notable papers authored include:

  • Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser Conization: A 5-year follow-up study, 2020, Gynecologic Oncology
  • Enhanced recovery after surgery (ERAS) in gynecology oncology, 2020, European Journal of Surgical Oncology
  • How to Select Early-Stage Cervical Cancer Patients Still Suitable for Laparoscopic Radical Hysterectomy: a Propensity-Matched Study, 2020, Annals of Surgical Oncology
  • Outcomes of High-Grade Cervical Dysplasia with Positive Margins and HPV Persistence after Cervical Conization, 2023, Vaccines
  • High-risk HPV-positive and -negative high-grade cervical dysplasia: Analysis of 5-year outcomes, 2021, Gynecologic Oncology

Best Publications

  • Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas.

    A. Bellacosa;D. De Feo;A. K. Godwin;D. W. Bell

  • CLASS III BETA-TUBULIN OVEREXPRESSION IS A PROMINENT MECHANISM OF PACLITAXEL RESISTANCE IN OVARIAN CANCER PATIENTS

    Simona Mozzetti;Cristiano Ferlini;Paola Concolino;Flavia Filippetti

  • A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study.

    Anna Fagotti;Gabriella Ferrandina;Francesco Fanfani;Alfredo Ercoli

  • Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome.

    Anna Fagotti;Gabriella Ferrandina;Giuseppe Vizzielli;Francesco Fanfani

  • Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial.

    Sandro Pignata;Giovanni Scambia;Dionyssios Katsaros;Ciro Gallo

  • Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target.

    G. Scambia;F. O. Ranelletti;P. Benedetti Panici;R. De Vincenzo

  • Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma.

    M Maurizi;G Almadori;G Ferrandina;M Distefano

  • Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Progressive or Recurrent Ovarian Cancer

    Gabriella Ferrandina;Manuela Ludovisi;Domenica Lorusso;Sandro Pignata

  • Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma.

    Anna Fagotti;Gabriella Ferrandina;Francesco Fanfani;Giorgia Garganese

  • Expression of CD133-1 and CD133-2 in ovarian cancer.

    G. Ferrandina;G. Bonanno;L. Pierelli;A. Perillo

  • Class III β-Tubulin Overexpression Is a Marker of Poor Clinical Outcome in Advanced Ovarian Cancer Patients

    Gabriella Ferrandina;Gian Franco Zannoni;Enrica Martinelli;Amelia Paglia

  • Preoperative local staging of endometrial cancer: transvaginal sonography vs. magnetic resonance imaging

    L. Savelli;M. Ceccarini;M. Ludovisi;E. Fruscella

  • Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients

    G. Ferrandina;L. Lauriola;M. G. Distefano;G. F. Zannoni

  • Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial

    Sandro Pignata;Giovanni Scambia;Gabriella Ferrandina;Antonella Savarese

  • Cells with Characteristics of Cancer Stem/Progenitor Cells Express the CD133 Antigen in Human Endometrial Tumors

    Sergio Rutella;Giuseppina Bonanno;Annabella Procoli;Andrea Mariotti

  • Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells

    Laura Rosanò;Roberta Cianfrocca;Francesca Spinella;Valeriana Di Castro

  • Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients

    G. Ferrandina;L. Lauriola;G. F. Zannoni;A. Fagotti

  • Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer.

    Valeria Masciullo;Alessandro Sgambato;Carmen Pacilio;Bruna Pucci

  • Analysis of cyclin E and CDK2 in ovarian cancer: gene amplification and RNA overexpression.

    Maria Marone;Giovanni Scambia;Cecilia Giannitelli;Gabriella Ferrandina

  • Bcl-2 Down-Regulation Is a Novel Mechanism of Paclitaxel Resistance

    Cristiano Ferlini;Giuseppina Raspaglio;Simona Mozzetti;Mariagrazia Distefano

Frequent Co-Authors

Giovanni Scambia
Giovanni Scambia Catholic University of the Sacred Heart
Salvatore Mancuso
Salvatore Mancuso Catholic University of the Sacred Heart
Domenica Lorusso
Domenica Lorusso Catholic University of the Sacred Heart
Sandro Pignata
Sandro Pignata National Cancer Institute
Francesco Cosentino
Francesco Cosentino Karolinska University Hospital
Pierluigi Benedetti Panici
Pierluigi Benedetti Panici Sapienza University of Rome
Fabio Ghezzi
Fabio Ghezzi University of Insubria
Nicoletta Colombo
Nicoletta Colombo University of Milano-Bicocca

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career in the USA doesn't always mean earning a traditional MD. Many students consider online degrees in related fields to increase their flexibility, reduce costs, and access growing job markets. For those interested in healthcare management, enrolling in one of the cheapest mha programs online allows you to gain practical leadership skills with minimal financial burden. This route appeals to students who wish to move into hospital administration or healthcare consultancy.

Similarly, those searching for advanced leadership roles can review the cheapest mha online programs for options that balance affordability with high-quality curriculum. Nursing professionals looking to expand their scope may be interested in the cheapest bsn to dnp programs, which provide a fast track from a Bachelor of Science in Nursing to a Doctor of Nursing Practice.

Pharmacy is another in-demand area, and online pharmacy schools are making it easier for students to earn a doctorate degree remotely. These varied pathways can help you enter the medical field, enhance your credentials, and open the door to a wide range of careers beyond a traditional physician’s role.

Best Scientists Citing Gabriella Ferrandina

Trending Scientists